These compounds were found to: (a) inhibit the expression of genes involved in cell migration in response to stromal cells-derived factor 1-α (SDF1-α, a chemokine that attracts breast cancer cells to the bone), and (b) to stimulate the expression of genes that increase tumour cell adhesion [51]. Here, CXCL12 is linked to breast carcinoma.